Doctor Clay Siegall has been working to advance the biotechnology field and cancer research since 1988. His background in the fields include working for the National Cancer Institute, National Institutes of Health from 1988 to 1991 as well as working for the Bristol-Myers Squibb Pharmaceutical Research Institute 1991 to 1997. In 1998, he stepped into a slightly new direction and co-founded Seattle Genetics. Since then he has remained Chief Executive Officer (CEO) of this prominent and progressive company.
Seattle Genetics (SGEN) Clay B. Siegall on Q2 2016 Results – Earnings Call Transcript
A very large part of Dr. Siegall forming Seattle Genetics was his passion for the growing field of monoclonal antibodies in 1997, he chose to pursue the field and start his own company. He did this instead of going back to the east coast when Bristol-Meyers Squibb when they closed their lab in Seattle in 1997.
During his time leading Seattle Genetics, Dr. Siegall has helped with capital-raising activities with both public and private financings, totaling more than $675 million which did include the company’s initial public offerings in 2001. One of the main driving forces for the capital is Seattle Genetics’ first commercial product, ADCETRIS® (brentuximab vedotin). Revolutionary and innovative, ADCETRIS® (brentuximab vedotin) is an Antibody-Drug Conjugate (ADC) that targets the antigens specific to cancers, Hodgkin lymphoma in particular. This new bio-technology is starting to lead the field in cancer therapies, giving people options they never had before.
Encouraged by strong clinical trials and highly positive results, ADCETRIS® (brentuximab vedotin) has been approved in 47 countries for use against cancer. This ADC and several others developed by Seattle Genetics are improving the overall health of patients by targeting the cancer specific antigens for cancer growth and reproduction, instead of targeting the whole area the cancer is in, healthy cells included. As a result, people are having fewer relapses and better recovery times with these new technologies.
With his passion and personable nature, Dr. Siegall works for his heart and the people he knows he, and his company, can help. Their creativity and drive consistently push the envelope of the ADC pharmaceutical industry in all the right ways.
In a recent PRN News article online Securus was voted number one for their monitoring and surveillance of inmate calls. They strive hard to maintain a level of customer service satisfaction that will meet the mandates of the federal government and serve the needs of inmates and their families. You won’t be disappointed with they way they ensure that you get the time that you were allotted with each call. Securus works closely with the Public Utility Commission to ensure all safety demands that are related to the public are met. They are the solution to the industries need for monitoring and quality assurance.
Two Companies Regulated By Securus
IC Solutions is regulated by Securus because they are an active inmate calling company. They have several features that have quickly become popular with inmates and their families. In fact, they have innovative calling features that allow family members to leave a message for inmates through a voicemail messaging system. When the inmate has access to their phone privileges they can retrieve their messages. It is a wonderful feature if you need an inmate to call you at a certain time.
Global Tel-Link is a great way for inmates to talk to their love ones for a fraction of the cost of their competitors. They have become the largest growing inmate provider in the nation. They have proudly processed over 3 billion inmates calls assisting thousands of inmates and their families. You can also get a prepaid account through Global Tel-Link called the Advanced Pay Program and Securus is proud to announce that this program is recommended for inmates and their families when they are interested in saving time and money. Visit the official Global Tel,-Link website for more details today.
Securus Video Visitation – Kids from Securus Technologies on Vimeo.
In business under one name or another since 1842, Laidlaw & Company is an investment banking firm with over 170 offices in the United States and Europe.
U.S. Federal Court Issues Temporary Restraining Order Against Laidlaw & Company And Its Principals Matthew Eitner And James Ahern
In December, 2015, the U.S. District Court of Nevada issued a legal injunction against Laidlaw & Company LTD, immediately halting all company efforts to take over Relmada Therapeutics, Inc. The injunction, which was issued with a temporary protection order against Laidlaw and its principals James Ahern and Matthew Eitner, prevents the company from continuing to provide false and misleading proxy materials in regards to their proposed takeover of Relmada Therapeutics and is the result of a lawsuit previously filed by Relmada.
Laidlaw & Company has had numerous legal problems in the past, mainly related to violating Federal financial regulations, and was at one point an investment banking service provider for Relmada. This relationship ended after a December, 2015, press release was issued by Relmada indicating that Laidlaw and it’s principals had caused negative consequences relating to the company’s NASDAQ listing and were providing false and misleading proxy information.
Matthew Eitner has served as CEO of Laidlaw & Company since 2011, and has extensive experience in the investment and equity trading industries. Mr. Eitner is also a founding member of the Board of Trustees for a Ramsey, New Jersey, Catholic preparatory high school. His associate James Ahern has been with Laidlaw & Company since 2010 as a managing partner and Head of Capital Markets. He was previously employed with Mr. Eitner at Aegis Capital Corp, and is a graduate of Northfield Mount Hermon School.
Brian Bonar is a former Executive of the Year. He is the CEO and Chairman of the Delrada Financial Corporation. Listed as a Who’s Who of the Year in Finance, he had been given this prestigious award in the 2010-2011 season. This is not to imply that Mr. Bonar has any intention of slowing down. In this discipline only two females and two males are named each year. Learn more about Brian Bonar: http://mg2.com/about/people/brian-bonar/
Brian Bonar has over 30 years experience in professional management in the financial services field. He also has responsibilities with two other major offshoots that benefit from his financial prowess. They are Allegiant Professional Business Services, Inc. and Smart-tek Automated Services Inc.
Brian Bonar has 30 plus years experience as a Financial Manager and consultant. In his 10 year post as CEO and Chairman, he has overseen employees, employer benefits and aftermarket products. These functions are the expertise he most often performs:Chairman and CEO.
An expert in increasing the efficiency of businesses,he isinvolved in how well these markets interact and is a key focus of his work.
Its fair to say that many employees enjoy enhanced benefits due to Brian Bonar’s unique abilities. Learn more about Brian Bonar: http://www.spokeo.com/Brian-Bonar
According to Bloomberg, Mr. Bonar holds a Ph.D. in Finance and Management and as such, handles his company’s business liability and Workmen’s Compensation. These are his particular strengthens and what distinguishes him from the pack.
Mr. Brian Bonar received an undergraduate degree from the University of Strathclyde and his MBA and doctorate degree from Staffordshire University,in the U,K. He has over 18 years experience with IBM in Europe, Asia and the United States.
To add to his already impressive resume we’d have to add an additional 20 plus years working in the United Kingdom and the United States. He is currently on the boards of Warning Management Services and Trucept Inc. Mr. Bonar is also serving as a board member at the Boys and Girls Club of Greater San Diego. He is also a member of the American Finance Association.
Read more: Brian Bonar | LinkedIn